Zur Kurzanzeige

2002-02-06Zeitschriftenartikel DOI: 10.1186/1471-2334-2-2
Immunity status against poliomyelitis in Germany: Determination of cut-off values in International Units
dc.contributor.authorDiedrich, Sabine
dc.contributor.authorClaus, Hermann
dc.contributor.authorSchreier, Eckart
dc.date.accessioned2018-05-07T14:45:41Z
dc.date.available2018-05-07T14:45:41Z
dc.date.created2011-09-01
dc.date.issued2002-02-06none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/reOe5u4aTcig/PDF/28QMApmtDZNLw.pdf
dc.identifier.urihttp://edoc.rki.de/176904/925
dc.description.abstractBackground: To prevent importations of wild polioviruses into a polio free region a high level of population immunity must be kept. Standard methodology for determination of polio antibodies is a feature aimed at obtaining consistent results. An International Standard Serum for polio antibodies exists, but no protective level in International Units is defined. Methods: A representative study was carried out in order to determine the serological status against poliomyelitis in Germany (n = 2564, age 18–79 years). Furthermore, sera from persons aged less than 18 years were included (n = 881). Microneutralization test has been used for determination of antibody levels. Results have been expressed in International Units. Results: The results of this study indicate that the cut-off level for polio antibodies is 0.075 IU/ml for Polio 1, 0.180 IU/ml for Polio 2 and 0.080 IU/ml for Polio 3. Neutralizing antibodies against poliovirus type 1, 2 and 3 were detected in 96.2%, 96.8% and 89.6% of samples, respectively. Conclusions: Overall, this seroprevalence indicates a very high level of immunity of the general population. It must be kept after the switch of immunization strategy from attenuated to inactivated vaccine in Germany.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionskrankheiten / Erreger
dc.subjectAdolescenteng
dc.subjectHumanseng
dc.subjectFemaleeng
dc.subjectGermanyeng
dc.subjectMaleeng
dc.subjectMiddle Agedeng
dc.subjectPopulation Surveillance/methodseng
dc.subjectAdulteng
dc.subjectAgedeng
dc.subjectAge Factorseng
dc.subjectSex Factorseng
dc.subjectImmunization Scheduleeng
dc.subjectAntibodies Viral/bloodeng
dc.subjectDisease Susceptibility/immunologyeng
dc.subjectImmunity Innateeng
dc.subjectInternational System of Units/standardseng
dc.subjectMathematical Computingeng
dc.subjectNeutralization Tests/standardseng
dc.subjectPoliomyelitis/epidemiologyeng
dc.subjectPoliomyelitis/immunologyeng
dc.subjectPoliomyelitis/prevention & controleng
dc.subjectPoliomyelitis/transmissioneng
dc.subjectPoliovirus/immunologyeng
dc.subjectPoliovirus Vaccines/therapeutic useeng
dc.subjectReference Standardseng
dc.subject.ddc610 Medizin
dc.titleImmunity status against poliomyelitis in Germany: Determination of cut-off values in International Units
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10015098
dc.identifier.doi10.1186/1471-2334-2-2
dc.identifier.doihttp://dx.doi.org/10.25646/850
local.edoc.container-titleBMC Infectious Diseases
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.biomedcentral.com/1471-2334/2/2/abstract/
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume2
local.edoc.container-issue2
local.edoc.container-year2002

Zur Kurzanzeige